BEIJING, Feb. 28, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has retained The Piacente Group ("TPG"), a full-service investor relations firm with offices in New York, California and Beijing, to support the Company's increased investor relations efforts.
"2010 was a record year for Dehaier, as we achieved strong growth across all key metrics and are poised for continued success in 2011. As such, we believe that the time is right to increase our communication with the investment community," said Mr. Ping Chen, CEO of Dehaier. "TPG has a sterling reputation, an expert team and a proven track record of providing value for emerging companies. We believe TPG is an ideal partner as we work toward the next level of growth, and look forward to working with the team."
Brandi Piacente, President of TPG added, "Dehaier Medical Systems is uniquely positioned in the fast-growing market for professional and homecare medical devices in China. The Company has a compelling growth story with its diversified product portfolio, extensive marketing channels and technological leadership in the medical device and homecare solutions market in China. We are excited to be working with Dehaier's executive team to develop and implement a proactive strategic communications and investor relations program aimed at raising visibility on Wall Street and maximizing shareholder value."
About Dehaier Medical Systems Ltd.Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), ResMed (Australia), and JMS (Japan). Dehaier's technology is based on two patents, six pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com.
Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.Contact UsIn the US:The Piacente Group, Inc. Investor Relations Brandi Floberg or Lee Roth(212) email@example.comIn China:The Piacente Group, Inc. Investor RelationsWendy Sun+86 firstname.lastname@example.orgDehaier Medical Systems LimitedRita LiuCFO+86 email@example.comAnan LiuInvestor Relations Manager+86 10-5166-0080 ext firstname.lastname@example.org
|SOURCE Dehaier Medical Systems Ltd.|
Copyright©2010 PR Newswire.
All rights reserved